139 related articles for article (PubMed ID: 23474631)
1. Functional-metabolic imaging of neuroblastoma.
Sharp SE; Parisi MT; Gelfand MJ; Yanik GA; Shulkin BL
Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):6-20. PubMed ID: 23474631
[TBL] [Abstract][Full Text] [Related]
2. PET/CT imaging in neuroblastoma.
Piccardo A; Lopci E; Conte M; Foppiani L; Garaventa A; Cabria M; Villavecchia G; Fanti S; Cistaro A
Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):29-39. PubMed ID: 23474633
[TBL] [Abstract][Full Text] [Related]
3. Disparities in uptake pattern of (123)I-MIBG, (18)F-FDG, and (99m)Tc-MDP within the same primary neuroblastoma.
Codreanu I; Zhuang H
Clin Nucl Med; 2014 Feb; 39(2):e184-6. PubMed ID: 23676656
[TBL] [Abstract][Full Text] [Related]
4. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
6. Imaging of non-central nervous system primitive neuroectodermal tumours: diagnostic features and correlation with outcome.
Dick EA; McHugh K; Kimber C; Michalski A
Clin Radiol; 2001 Mar; 56(3):206-15. PubMed ID: 11247698
[TBL] [Abstract][Full Text] [Related]
7. Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy.
Takano A; Oriuchi N; Tsushima Y; Taketomi-Takahashi A; Nakajima T; Arisaka Y; Higuchi T; Amanuma M; Endo K
Ann Nucl Med; 2008 Jun; 22(5):395-401. PubMed ID: 18600417
[TBL] [Abstract][Full Text] [Related]
8. Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors.
Liu B; Zhuang H; Servaes S
Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):21-8. PubMed ID: 23474632
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma: imaging evaluation by sequential Tc-99m MDP, I-131 MIBG, and Ga-67 citrate studies.
Garty I; Friedman A; Sandler MP; Kedar A
Clin Nucl Med; 1989 Jul; 14(7):515-22. PubMed ID: 2766633
[TBL] [Abstract][Full Text] [Related]
10. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
Sautter-Bihl ML; Bihl H; Heinze HG
Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
[TBL] [Abstract][Full Text] [Related]
11. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
12. Integrated imaging using MRI and 123I metaiodobenzylguanidine scintigraphy to improve sensitivity and specificity in the diagnosis of pediatric neuroblastoma.
Pfluger T; Schmied C; Porn U; Leinsinger G; Vollmar C; Dresel S; Schmid I; Hahn K
AJR Am J Roentgenol; 2003 Oct; 181(4):1115-24. PubMed ID: 14500242
[TBL] [Abstract][Full Text] [Related]
13. Bone and lymph node metastases from neuroblastoma detected by 18F-DOPA-PET/CT and confirmed by posttherapy 131I-MIBG but negative on diagnostic 123I-MIBG scan.
Piccardo A; Lopci E; Conte M; Cabria M; Cistaro A; Garaventa A; Villavecchia G
Clin Nucl Med; 2014 Jan; 39(1):e80-3. PubMed ID: 23579975
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
Turba E; Fagioli G; Mancini AF; Rosito P; Galli A; Alvisi P
J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
Rufini V; Treglia G; Castaldi P; Perotti G; Calcagni ML; Corsello SM; Galli G; Fanti S; Giordano A
Nucl Med Commun; 2011 Jul; 32(7):575-82. PubMed ID: 21471850
[TBL] [Abstract][Full Text] [Related]
16. [Current strategy for the imaging of neuroblastoma].
Brisse H; Edeline V; Michon J; Couanet D; Zucker J; Neuenschwander S
J Radiol; 2001 Apr; 82(4):447-54. PubMed ID: 11353899
[TBL] [Abstract][Full Text] [Related]
17. Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.
Taggart DR; Han MM; Quach A; Groshen S; Ye W; Villablanca JG; Jackson HA; Mari Aparici C; Carlson D; Maris J; Hawkins R; Matthay KK
J Clin Oncol; 2009 Nov; 27(32):5343-9. PubMed ID: 19805691
[TBL] [Abstract][Full Text] [Related]
18. Does I-131-MIBG underestimate skeletal disease burden in neuroblastoma?
Barai S; Bandopadhayaya GP; Malhotra A; Agarwal S; Kumar R; Dhanapathi H
J Postgrad Med; 2004; 50(4):257-60; discussion 260-1. PubMed ID: 15623965
[TBL] [Abstract][Full Text] [Related]
19. Contemporary approach to diagnosis and treatment of neuroblastoma.
Charron M
Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):40-52. PubMed ID: 23474634
[TBL] [Abstract][Full Text] [Related]
20. Role of iodine-131 MIBG scanning in the management of paediatric patients with neuroblastoma.
Shah Syed GM; Naseer H; Usmani GN; Cheema MA
Med Princ Pract; 2004; 13(4):196-200. PubMed ID: 15181323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
